BCWORLD PHARM. Statistics

Total Valuation

BCWORLD PHARM. has a market cap or net worth of KRW 40.29 billion. The enterprise value is 120.67 billion.

Market Cap	40.29B
Enterprise Value	120.67B

Important Dates

The next estimated earnings date is Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

BCWORLD PHARM. has 9.28 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	9.28M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	40.66%
Owned by Institutions (%)	n/a
Float	5.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.54
PB Ratio	0.53
P/TBV Ratio	0.54
P/FCF Ratio	24.50
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.13, with an EV/FCF ratio of 73.38.

EV / Earnings	-27.22
EV / Sales	1.61
EV / EBITDA	13.13
EV / EBIT	80.45
EV / FCF	73.38

Financial Position

The company has a current ratio of 0.52, with a Debt / Equity ratio of 1.17.

Current Ratio	0.52
Quick Ratio	0.34
Debt / Equity	1.17
Debt / EBITDA	9.68
Debt / FCF	54.10
Interest Coverage	0.32

Financial Efficiency

Return on equity (ROE) is -4.26% and return on invested capital (ROIC) is 0.56%.

Return on Equity (ROE)	-4.26%
Return on Assets (ROA)	0.52%
Return on Invested Capital (ROIC)	0.56%
Return on Capital Employed (ROCE)	1.66%
Revenue Per Employee	263.43M
Profits Per Employee	-15.61M
Employee Count	284
Asset Turnover	0.42
Inventory Turnover	2.93

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.57% in the last 52 weeks. The beta is -0.08, so BCWORLD PHARM.'s price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	-28.57%
50-Day Moving Average	4,626.30
200-Day Moving Average	4,694.46
Relative Strength Index (RSI)	41.34
Average Volume (20 Days)	4,360

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BCWORLD PHARM. had revenue of KRW 74.81 billion and -4.43 billion in losses. Loss per share was -477.52.

Revenue	74.81B
Gross Profit	28.01B
Operating Income	1.50B
Pretax Income	-2.77B
Net Income	-4.43B
EBITDA	9.19B
EBIT	1.50B
Loss Per Share	-477.52

Full Income Statement

Balance Sheet

The company has 7.91 billion in cash and 88.95 billion in debt, giving a net cash position of -81.04 billion or -8,730.77 per share.

Cash & Cash Equivalents	7.91B
Total Debt	88.95B
Net Cash	-81.04B
Net Cash Per Share	-8,730.77
Equity (Book Value)	76.01B
Book Value Per Share	8,259.46
Working Capital	-41.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.04 billion and capital expenditures -2.40 billion, giving a free cash flow of 1.64 billion.

Operating Cash Flow	4.04B
Capital Expenditures	-2.40B
Free Cash Flow	1.64B
FCF Per Share	177.15

Full Cash Flow Statement

Margins

Gross margin is 37.44%, with operating and profit margins of 2.00% and -5.92%.

Gross Margin	37.44%
Operating Margin	2.00%
Pretax Margin	-3.70%
Profit Margin	-5.92%
EBITDA Margin	12.29%
EBIT Margin	2.00%
FCF Margin	2.20%

Dividends & Yields

This stock pays an annual dividend of 90.91, which amounts to a dividend yield of 2.07%.

Dividend Per Share	90.91
Dividend Yield	2.07%
Dividend Growth (YoY)	10.00%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	2.07%
Earnings Yield	-11.00%
FCF Yield	4.08%

Dividend Details

Stock Splits

The last stock split was on December 27, 2024. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 27, 2024
Split Type	Forward
Split Ratio	1.1

Scores

BCWORLD PHARM. has an Altman Z-Score of 0.79. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.79
Piotroski F-Score	n/a